KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Other Non Operating Income (2016 - 2025)

Bausch Health Companies' Other Non Operating Income history spans 17 years, with the latest figure at $203.0 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 390.0% year-over-year to $203.0 million; the TTM value through Dec 2025 reached -$29.0 million, up 69.79%, while the annual FY2025 figure was $162.0 million, 444.68% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $203.0 million at Bausch Health Companies, up from -$410.0 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $570.0 million in Q3 2022 and bottomed at -$410.0 million in Q3 2025.
  • The 5-year median for Other Non Operating Income is -$3.0 million (2021), against an average of $30.3 million.
  • The largest annual shift saw Other Non Operating Income skyrocketed 18900.0% in 2022 before it tumbled 7100.0% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at -$73.0 million in 2021, then soared by 363.01% to $192.0 million in 2022, then plummeted by 99.48% to $1.0 million in 2023, then crashed by 7100.0% to -$70.0 million in 2024, then soared by 390.0% to $203.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Other Non Operating Income are $203.0 million (Q4 2025), -$410.0 million (Q3 2025), and $178.0 million (Q2 2025).